Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MO BIO Laboratories was a leading provider of innovative molecular biology tools—especially for DNA and RNA isolation from challenging environmental samples such as soil. Their products became industry standards among environmental microbiology researchers due to their effectiveness at removing PCR inhibitors like humic acids. The company was acquired by QIAGEN and now operates as part of QIAGEN’s portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MO BIO Laboratories.